Intressa Vascular announces the start of the EXTENSO clinical study
Intressa Vascular is starting a clinical study to evaluate the effectiveness and safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection (TBAD) in patients eligible for thoracic endovascular repair with stent grafts, the EXtensive mulTilayer stEnt treatmeNt in aortic disSectiOn study, to reduce reinterventions and rupture of the aorta in patients with extended TBAD.
The Allay® Aortic Stent wins the 2024 Prix Galien for Most Promising Design
The Prix Galien, often likened to the Nobel Prize of medical innovation on the international stage, celebrates the most significant advancements in healthcare.
Intressa Vascular secures EUR 13 million in financing
Intressa Vascular secures EUR 13 million in financing to support the development of its innovative multilayer Allay™ Aortic Stent for the treatment of aortic dissection
Long-term results of the prospective aortic dissection DRAGON study presented at CX2023
On April 27, 2023, the investigators, represented by Prof. Dr Victor Costache, presented at CX Symposium 2023 the “Long-term safety outcomes of patients with type B aortic dissection treated with multilayer stents: Results from a prospective multicenter pilot study”
